ActiPatch(TM) Product Quickly Approaches World-wide Availability
FREDERICK, Md., July 17 /PRNewswire-FirstCall/ -- BioElectronics Corporation (Pink Sheets: BIEL) announces today a new distribution agreement with Piramal Healthcare Limited has been made for distribution of BioElectronic's revolutionary ActiPatch product.
Piramal Healthcare Limited (earlier Nicholas Piramal India Limited) is one of India's largest companies with strong brand management and sales capabilities. PHL has emerged among the leaders in Indian pharma with one of the widest product portfolios in India.
Andrew J. Whelan, CEO of BioElectronics Corporation, explains, "This is an important and significant order for BioElectronics Corporation. We continue to be excited about developing strong sales in the international marketplace. Piramal Healthcare is an aggressive player and the right partner to help us roll our product out into one of the most populous countries in the world."
Dr. Swati Piramal, Director, Piramal Healthcare Ltd., said, "At Piramal we believe that we should care for the world we share and serve. With the Actipatch launch, we are delighted to bring a breakthrough technology to India to offer a cost effective healing solution." Actipatch(TM), the product marketed by BioElectronics Corp. is changing the face of medicine and the way we heal. Recently chosen as "One of 9 Medical Breakthroughs That May Change Your Life," by Medical Headway.com, ActiPatch is fast becoming the treatment of choice for everything in soft tissue injuries including surgical recovery.
ActiPatch is a drug-free wafer thin patch with an embedded battery-operated microchip that delivers weeks of continuous pulsed RF therapy for less than a dollar a day. The unique ActiPatch delivery system, using patented technology, provides a cost-effective, home use method that reduces soft tissue pain and swelling, and accelerates healing.
Piramal Healthcare will distribute ActiPatch in the Indian market both on medical and retail levels in August 2008.
For more information visit http://www.bioelectronicscorp.com or call 866-757-2284.
Information on ActiPatch and BioElectronics Corporation is available at
the following websites:
-- U.S. Consumer http://www.actipatchonline.com
-- Podiatry: http://www.pemfpodiatry.com
-- German orthopedic foot & ankle: http://www.diesfussexperten.de
-- Italy and Switzerland: http://www.actipatch.it
-- Canada: http://www.actipatchpaintherapy.ca
-- Netherlands: http://www.actipatch.de
-- Singapore & Malaysia: http://www.astonixlife.com/
-- BioElectronics Corp: http://www.bioelectronicscorp.com
About Piramal Healthcare Limited
Piramal Healthcare Ltd. is one of India's largest pharmaceutical companies, with a growth track record of above 30% CAGR since 1988. Piramal Healthcare had consolidated revenues of US$ 718 million in FY2008. The Company is currently ranked 4th in the Indian market with a diverse product portfolio spanning nine therapeutic areas. The Company is also one of the largest custom manufacturing companies with a global footprint of assets across North America, Europe and Asia. Piramal Healthcare is listed in India on the National Stock Exchange (Ticker: PIRHEALTH) and the Bombay Stock Exchange (Ticker: 500302).
Safe Harbor Statement
This news release contains forward-looking statements related to future
growth and earnings opportunities. Such statements are based upon certain
assumptions and assessments made by management in light of current
conditions, expected future developments and other factors it believes to
be appropriate. Actual results may differ as a result of factors over which
the company has no control.
Media Relations Contact:
Patricia Baker, The Big Picture Agency LLC
Voice: 413-623-0950 ext. 221, email: email@example.com
Investor Relations Contact:
Joe Noel, Emerging Growth Research LLP
Voice: 925-922-2560, email: firstname.lastname@example.org
|SOURCE BioElectronics Corporation|
Copyright©2008 PR Newswire.
All rights reserved